Immutep Granted Chinese Patent for Eftilagimod Alpha, a Soluble Lag-3 Protein, in Combination with a Chemotherapy Agent

Amy Giles
Increasing Engagement

Matthew Durham
Omnidynamic Marketing

Pat Purcell
Meeting Engagement

Daniel Sontupe
Market Access

David Linetsky
Point-of-Care Marketing

Suma Ramadas, PhD
Medical Affairs

Liz Kane
Impactful Strategy

Paul Theisen
Patient Acquisition

Matt Turner
Patient Affordability

Bud Bilanich
Success Coach

Frank Burrell
Scientific Storytelling

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence